After menopause, women can benefit greatly from strength training and balance exercises to maintain bone density, muscle mass, and prevent falls. The article emphasizes resistance exercises like weightlifting, bodyweight movements, and impact training, along with balance activities such as yoga or tai chi, as effective ways to stay healthy and strong post-menopause.
Federal guidelines now allow women aged 30-65 at average risk to choose self-administered HPV tests every five years for cervical cancer screening, providing a more private and accessible option alongside traditional Pap smears, with the aim of increasing screening rates and early detection.
A woman shares her journey from suffering in silence with post-birth urinary incontinence to discovering that minimally invasive treatments like bulking agent injections can be highly effective, highlighting the lack of awareness and the need for better education on women's health options.
Many women overlook their pelvic floor muscles, which support vital organs and influence sexual, urinary, and digestive health. Factors like aging, childbirth, and hormone changes can weaken these muscles, leading to issues like leaks and pelvic pain. Preventative measures include exercises like Kegels, addressing vaginal dryness, managing constipation, and seeking medical advice for symptoms, to maintain pelvic health as women age.
A woman shares her harrowing experience of being dismissed by her doctor despite symptoms of a rare, aggressive cancer, highlighting issues of gender bias, systemic healthcare delays, and the importance of self-advocacy in medical care. Her story underscores the critical need for patients to persist in seeking timely diagnosis and treatment, especially for women and those with rare conditions.
Women taking Ozempic report experiencing 'Ozempic vulva,' a side effect causing changes in vaginal appearance, leading some to spend up to £2,000 on corrective procedures like labia puffing with fillers. Experts warn about potential risks and emphasize the importance of consulting qualified healthcare providers, while the manufacturer advises using the medication only for approved indications and reporting side effects.
The European Parliament voted in favor of establishing an EU fund to expand access to abortion across member states, supporting reproductive rights and healthcare equality, despite political divisions and varying national laws.
The FDA has approved the use of Addyi, a libido-boosting pill, for women over 65 who are postmenopausal, expanding its previous use for premenopausal women, despite concerns over side effects and effectiveness.
The FDA has approved the use of Addyi, a libido-boosting pill, for women over 65 who have gone through menopause, expanding its previous approval for premenopausal women, despite concerns about side effects and the controversial nature of diagnosing low sexual desire as a medical condition.
The FDA has expanded the approval of the libido drug Addyi to include women over 65 who are postmenopausal, after initial approval for premenopausal women. Despite past concerns over side effects and modest effectiveness, the drug's approval reflects ongoing efforts to address female sexual health issues.
A new drug offers promising advancements in the treatment of postpartum depression, potentially improving outcomes for new mothers suffering from this condition.
US health leaders are advocating for the removal of the black box warning on hormone therapy for menopause, citing new evidence of its benefits and calling for balanced, individualized treatment discussions, though some experts warn of potential risks and the need for nuanced understanding.
The FDA plans to remove safety warnings from hormone replacement therapy products used for menopause, sparking debate about balancing risks and benefits, with experts emphasizing the need for informed, personalized decision-making.
Science and medical guidelines have evolved, leading to a more nuanced view of hormone therapy for menopause. Starting therapy before age 60 or within ten years of menopause can provide relief from symptoms like hot flashes and night sweats, and offer benefits for bone and heart health. However, not all women are suitable candidates, and risks vary depending on the type of estrogen used and individual health conditions. Alternatives like non-hormonal medications and lifestyle changes are also available for managing menopausal symptoms.
The FDA has removed the 'black box' warning on hormone replacement therapy for menopause, citing new research that shows the treatments are safer than previously thought, which may increase their use among women and doctors. The agency will still warn about endometrial cancer risk and has approved two new menopause-related drugs. This change follows a reevaluation of past studies linking hormone therapy to serious health risks, and reflects a broader shift in conversations about women's health during midlife.